A New Era of Molecular Medicine, Regulation & Globalization Calls for a New Model for CDx

Time: 9:00 am
day: Conference Day One - AM


  • Molecular medicine is advancing so rapidly that the classic CDx model will need to evolve
  • Rather than CDx being the end of a pharma-Dx journey, it is proving to be just the beginning, with far greater integration into the precision medicine ecosystem and a loop back into discovery
  • We will share Guardant’s emergent Dx and data model and how it interacts with dynamics in regulation, reimbursement and market practices in Europe